51![Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in Treatments for MS: Gilenya ® (fingolimod) There are currently several disease-modifying therapies approved for people with MS in](https://www.pdfsearch.io/img/32b74aeaf2ed0ede3d6afc884262367e.jpg) | Add to Reading ListSource URL: www.mssociety.org.auLanguage: English - Date: 2015-03-01 21:43:46
|
---|
52![[Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS) [Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS)](https://www.pdfsearch.io/img/f089e19076e5b2058819eda778b02015.jpg) | Add to Reading ListSource URL: www.mssociety.org.au- Date: 2012-08-27 21:10:14
|
---|
53![[Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS) [Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS)](https://www.pdfsearch.io/img/ee7818fef7ca1f14eb581f1a8e41eb47.jpg) | Add to Reading ListSource URL: www.mssociety.org.au- Date: 2012-08-27 21:10:13
|
---|
54![](https://www.pdfsearch.io/img/1a2ce0c6674e49cfff625368c6786876.jpg) | Add to Reading ListSource URL: d1qmnn0xkv8u83.cloudfront.netLanguage: English - Date: 2015-03-11 21:00:06
|
---|
55![Multiple Sclerosis: The Nurse Practitioner’s Handbook Carrie Sammarco, DrNP, FNP-C, MSCN Multiple Sclerosis: The Nurse Practitioner’s Handbook Carrie Sammarco, DrNP, FNP-C, MSCN](https://www.pdfsearch.io/img/3882790e2267bb3c804d30fb22a75c27.jpg) | Add to Reading ListSource URL: www.nationalmssociety.orgLanguage: English - Date: 2015-02-19 10:18:10
|
---|
56![[Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS) [Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS)](https://www.pdfsearch.io/img/f4b0f8ae66f89e00e9bad5d1a7d4af23.jpg) | Add to Reading ListSource URL: www.mssociety.org.au- Date: 2012-08-27 21:10:15
|
---|
57![Medication Update Multiple Sclerosis Limited Treatment & Management of MS Medical Management Medication Update Multiple Sclerosis Limited Treatment & Management of MS Medical Management](https://www.pdfsearch.io/img/de31227fbf74872e1cf3ba42fe8617f5.jpg) | Add to Reading ListSource URL: www.mssociety.org.auLanguage: English - Date: 2014-11-23 22:35:23
|
---|
58![MSSocietyWA_32ppA4_TheBulletin_Autumn14_V8.indd MSSocietyWA_32ppA4_TheBulletin_Autumn14_V8.indd](https://www.pdfsearch.io/img/9bb1927b89898eff9860e175742675f5.jpg) | Add to Reading ListSource URL: d1qmnn0xkv8u83.cloudfront.netLanguage: English - Date: 2014-04-11 01:45:07
|
---|
59![[Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS) [Optional opening paragraph] For example, there has been a lot of attention and hype surrounding CCSVI as a possible cause, with a subsequent treatment (or cure), for multiple sclerosis (MS)](https://www.pdfsearch.io/img/d4b2db1ecdcc11df015ae838f886d306.jpg) | Add to Reading ListSource URL: www.mssociety.org.au- Date: 2012-08-27 21:10:16
|
---|
60![Post-market Review of Authority Required PBS Listings: Public Consultation Submission from Biogen Idec (Australia) Pty Ltd regarding disease-modifying therapies for Multiple Sclerosis (first tranche of reviews) Dear PBAC Post-market Review of Authority Required PBS Listings: Public Consultation Submission from Biogen Idec (Australia) Pty Ltd regarding disease-modifying therapies for Multiple Sclerosis (first tranche of reviews) Dear PBAC](https://www.pdfsearch.io/img/20ad6058b984625e5b2c4f32ef6f4bc3.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-04 00:10:33
|
---|